A detailed history of Kovack Advisors, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Kovack Advisors, Inc. holds 1,257 shares of VRTX stock, worth $566,115. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,257
Previous 1,212 3.71%
Holding current value
$566,115
Previous $568,000 2.82%
% of portfolio
0.06%
Previous 0.06%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$460.0 - $505.78 $20,700 - $22,760
45 Added 3.71%
1,257 $584,000
Q2 2024

Aug 02, 2024

BUY
$392.81 - $485.53 $49,886 - $61,662
127 Added 11.71%
1,212 $568,000
Q1 2024

Apr 19, 2024

BUY
$407.69 - $446.08 $2,038 - $2,230
5 Added 0.46%
1,085 $453,000
Q4 2023

Feb 02, 2024

BUY
$343.0 - $410.68 $14,063 - $16,837
41 Added 3.95%
1,080 $439,000
Q3 2023

Oct 19, 2023

BUY
$338.18 - $362.46 $25,701 - $27,546
76 Added 7.89%
1,039 $361,000
Q2 2023

Jul 21, 2023

SELL
$314.42 - $351.91 $16,664 - $18,651
-53 Reduced 5.22%
963 $338,000
Q1 2023

Apr 20, 2023

BUY
$283.23 - $323.1 $20,109 - $22,940
71 Added 7.51%
1,016 $320,000
Q4 2022

Feb 22, 2023

BUY
$285.76 - $321.48 $23,432 - $26,361
82 Added 9.5%
945 $272,000
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $219,611 - $245,035
-802 Reduced 48.17%
863 $250,000
Q2 2022

Aug 10, 2022

SELL
$234.96 - $292.55 $272,788 - $339,650
-1,161 Reduced 41.08%
1,665 $469,000
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $159,643 - $188,159
721 Added 34.25%
2,826 $737,000
Q4 2021

Jan 18, 2022

BUY
$177.01 - $223.45 $372,606 - $470,362
2,105 New
2,105 $462,000
Q1 2021

May 04, 2021

SELL
$207.02 - $241.31 $226,479 - $263,993
-1,094 Closed
0 $0
Q4 2020

Jan 14, 2021

SELL
$207.01 - $276.09 $107,645 - $143,566
-520 Reduced 32.22%
1,094 $259,000
Q3 2020

Nov 02, 2020

BUY
$255.65 - $303.1 $34,768 - $41,221
136 Added 9.2%
1,614 $439,000
Q2 2020

Jul 31, 2020

BUY
$225.48 - $295.8 $15,558 - $20,410
69 Added 4.9%
1,478 $429,000
Q1 2020

Apr 30, 2020

BUY
$199.77 - $247.81 $281,475 - $349,164
1,409 New
1,409 $335,000
Q3 2019

Oct 31, 2019

SELL
$166.23 - $187.09 $192,328 - $216,463
-1,157 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$164.61 - $190.37 $42,140 - $48,734
-256 Reduced 18.12%
1,157 $212,000
Q1 2019

May 03, 2019

SELL
$163.73 - $194.7 $11,624 - $13,823
-71 Reduced 4.78%
1,413 $260,000
Q4 2018

Feb 06, 2019

BUY
$151.91 - $192.21 $9,114 - $11,532
60 Added 4.21%
1,484 $246,000
Q3 2018

Oct 09, 2018

BUY
$167.73 - $192.74 $238,847 - $274,461
1,424 New
1,424 $274,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Kovack Advisors, Inc. Portfolio

Follow Kovack Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.